Hematology and Covid-19

COVID-19 is a systemic disease with a significant impact on the hematopoietic system and hemostasis. Patients with cancer may be huge susceptible to and have higher morbidity and mortality rates from COVID-19 than the general population, while epidemiologic data specifically addressed to hematologic patients are limited. The prevalence of COVID-19 in hematologic patients, mostly affected by malignancies, was not significantly higher compared to that of the general population. The revision enlightens on the epidemiology, risk factors and outcomes of COVID-19 among patients with HM. While the COVID-19 vaccinations will lead to a marked reduction of infections in HM patients, the possibility of a lower efficacy of vaccinations needs to be taken into account and possibly resembling previous experiences with influenza vaccination. 

Related Tags: Hematology Conference | Hematology conferences 2024 | Hematology conferences | Hematology conferences 2024 | Hematology Congress | Hematology Congress 2024 | Hematology meetings | Hematology meeting 2024 | Hematology summit | Hematology summit 2024 | Leukemia conference | Leukemia conferences | Leukemia conference 2024 | Leukemia conferences 2024 | Leukemia congress | Leukemia congress 2024 | Leukemia meeting | Leukemia meetings | Leukemia meeting 2024 | Leukemia meetings 2024 | Leukemia summit | Leukemia summit 2024 | Lymphoma congress | Lymphoma congress 2024 | Lymphoma summit | Lymphoma summit 2024 | Lymphoma meeting | Lymphoma meeting 2024 | Myelofibrosis | Myelofibrosis 2024 | Myelofibrosis congress | Myelofibrosis congress 2024

Related Associations: Hematology/Oncology Pharmacy Association | Hospice & Palliative Nurses Association | Institute of Medicine of the National Academies | International Association of Cancer Registries | International Association for the Study of Lung Cancer | International Collaboration on Cancer Reporting | International Extranodal Lymphoma Study Group | International Federation of Head and Neck Oncologic Societies | International Gynecologic Cancer Society